IP Library Granted Patent US 11,191,735
Granted Patent B2
US 11,191,735 · App. 15/068,350 · Granted Dec 7, 2021

Arginine silicate for periodontal disease

Inventors: James R Komorowski (Trumbull, CT); Kazim Sahin (Elaziğ, TR)
Assignee: NUTRITION 21, LLC
A61K31/047A61K9/0063A61K31/198A61K33/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,191,735
App. No.
15/068,350
Granted
Dec 7, 2021
Kind
B2
Abstract

Methods for treating and/or preventing periodontal disease with arginine silicate are disclosed. Methods may include the steps of identifying an individual in need of treatment for, or in need of prevention of, periodontal disease and administering an effective amount of an arginine-silicate complex to said individual. Arginine silicate may also be used to ameliorate one or more symptoms of periodontal disease. In some aspects, arginine silicate may be used to restore gum health and/or stop or reverse recession of the gums and/or the loss of gum tissue in the oral cavity.

Claims (7)

1. A method of treating periodontal disease in an individual in need thereof comprising:

topically administering an effective amount of an arginine-silicate complex to an individual's oral cavity in need of treatment for periodontal disease; wherein the arginine-silicate complex comprises arginine, silicate, and inositol; wherein the effective amount of the arginine-silicate complex is in a toothpaste; and wherein the periodontal disease is selected from the list consisting of gingivitis, periodontitis, tooth decay, enamel erosion and combinations thereof.

2. The method of claim 1 , wherein the periodontal disease comprises tooth decay.

3. The method of claim 1 , wherein the periodontal disease comprises enamel erosion.

4. The method of claim 1 , wherein the periodontal disease comprises gingivitis.

5. The method of claim 1 , further comprising the step of identifying an individual in need of treatment for periodontal disease wherein the identifying comprises physical examination by a dental hygienist, dentist, oral surgeon, orthodontist, or medical doctor.

6. The method of claim 1 , wherein the effective amount is between about 2 mg and about 2,500 mg.

Assignments (3)
SECURITY INTEREST Recorded Nov 9, 2021
From: NUTRITION 21, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 058060/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2021
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 056933/0653 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2016
From: KOMOROWSKI, JAMES R.; SAHIN, KAZIM
To: JDS THERAPEUTICS, LLC
Reel/Frame 038657/0032 →
Cited By (1)
US 12,653,219